皇家华人

header-logo
GettyImages-609179959-hero
headshot

Kathryn A. Bylow, MD

Associate Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital
  • Breast Care Center - Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology

Languages

  • English

Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Kathryn Bylow, MD, is Associate Professor of Medicine in the Division of Hematology and Oncology, specializing in genitourinary malignancies (prostate cancer, kidney cancer, bladder cancer and testicular cancer). She also has expertise in caring for older cancer patients and is Board certified in both medical oncology and geriatrics.

A native of Milwaukee, Dr. Bylow received her medical degree from the University of Wisconsin-Madison in 2000 and went on to obtain her internal medicine residency training at Vanderbilt University. She completed her fellowship training in both medical oncology and geriatrics at the University of Chicago during which time she received the American Society of Clinical Oncology Young Investigator Award for her work studying the link between prostate cancer treatment and the development of frailty in older men.

Research Interests

Her current research interests include investigator-initiated research evaluating treatment-related toxicities in older men with prostate cancer. She is also the principal investigator of several clinical trials evaluating the use of novel drugs in prostate, kidney, and bladder cancer.

Publications

  • (Atallah E, Bylow K, Troy J, Saber W.) Curr Hematol Malig Rep. 2014 Mar;9(1):57-65 PMID: 24398726 PMCID: PMC4031643 SCOPUS ID: 2-s2.0-84896710555 01/09/2014

  • (Grivas PD, Daignault S, Tagawa ST, Nanus DM, Stadler WM, Dreicer R, Kohli M, Petrylak DP, Vaughn DJ, Bylow KA, Wong SG, Sottnik JL, Keller ET, Al-Hawary M, Smith DC, Hussain M.) Cancer. 2014 Mar 01;120(5):692-701 PMID: 24249435 SCOPUS ID: 2-s2.0-84896703767 11/20/2013

  • (Ramsdale E, Polite B, Hemmerich J, Bylow K, Kindler HL, Mohile S, Dale W.) J Am Geriatr Soc. 2013 Nov;61(11):2043-4 PMID: 24219208 SCOPUS ID: 2-s2.0-84887505934 11/14/2013

  • (Bylow K, Hemmerich J, Mohile SG, Stadler WM, Sajid S, Dale W.) Urology. 2011 Apr;77(4):934-40 PMID: 21269665 PMCID: PMC3074039 SCOPUS ID: 2-s2.0-79953849203 01/29/2011

  • (Mohile SG, Mustian K, Bylow K, Hall W, Dale W.) Crit Rev Oncol Hematol. 2009 Jun;70(3):235-55 PMID: 18952456 PMCID: PMC3074615 SCOPUS ID: 2-s2.0-67349141307 10/28/2008

  • (Mohile SG et al..) Crit Rev Oncol Hematol. 2009 May 14: PMID: 19446466 05/19/2009

  • (Dale W, Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM.) J Clin Oncol. 2009 Apr 01;27(10):1557-63 PMID: 19255325 PMCID: PMC2738613 SCOPUS ID: 2-s2.0-63749112245 03/04/2009

  • (Bylow KA, Atkins MB, Posadas EM, Stadler WM, McDermott DF.) Clin Genitourin Cancer. 2009 Jan;7(1):39-42 PMID: 19213667 SCOPUS ID: 2-s2.0-65249089759 02/14/2009

  • (Bylow K, Dale W, Mustian K, Stadler WM, Rodin M, Hall W, Lachs M, Mohile SG.) Urology. 2008 Aug;72(2):422-7 PMID: 18561991 PMCID: PMC3032402 SCOPUS ID: 2-s2.0-48349102661 06/20/2008

  • (Bylow K, Mohile SG, Stadler WM, Dale W.) Cancer. 2007 Dec 15;110(12):2604-13 PMID: 17960609 SCOPUS ID: 2-s2.0-37049038470 10/26/2007

  • (Ryan CW, Huo D, Bylow K, Demers LM, Stadler WM, Henderson TO, Vogelzang NJ.) BJU Int. 2007 Jul;100(1):70-5 PMID: 17552955 SCOPUS ID: 2-s2.0-34249950226 06/08/2007

  • (Mohile SG, Bylow K, Dale W, Dignam J, Martin K, Petrylak DP, Stadler WM, Rodin M.) Cancer. 2007 Feb 15;109(4):802-10 PMID: 17219443 SCOPUS ID: 2-s2.0-33846905273 01/16/2007

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.